The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to Cylembio. KEYTRUDA ® is a ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...

A cancer vaccine will be available to women within a few months in India, Union Minister of State for Health, Family Welfare ...

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

The new treatment option is known as tumor-infiltrating lymphocyte (TIL) therapy. It’s designed for patients with metastatic ...

Medical experts emphasize the significance of early cancer detection. Learn about seven crucial warning signs that could ...

The American Cancer Society (ACS) has released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and ...

My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.